SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-470574"
 

Sökning: id:"swepub:oai:DiVA.org:uu-470574" > Possible Extraction...

Possible Extraction of Drugs from Lung Tissue During Broncho-alveolar Lavage Suggest Uncertainty in the Procedure's Utility for Quantitative Assessment of Airway Drug Exposure

Backstrom, E. (författare)
AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp & Immunol, Gothenburg, Sweden.
Erngren, T. (författare)
AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp & Immunol, Gothenburg, Sweden.
Fihn, B-M (författare)
AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp & Immunol, Gothenburg, Sweden.
visa fler...
Sadiq, M. W. (författare)
AstraZeneca, BioPharmaceut R&D, Clin Pharmacol & Safety Sci, Clin Pharmacol & Quantitat Pharmacol, Gothenburg, Sweden.
Lindberg, W. (författare)
AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp & Immunol, Gothenburg, Sweden.
Fridén, Markus (författare)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Institutionen för farmaci,AstraZeneca, Inhalat Prod Dev, Pharmaceut Technol & Dev, Operat, Gothenburg, Sweden.
Grime, K. (författare)
AstraZeneca, BioPharmaceut R&D, Biosci COPD IPF, Res & Early Dev,Resp & Immunol, Gothenburg, Sweden.
visa färre...
AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp & Immunol, Gothenburg, Sweden AstraZeneca, BioPharmaceut R&D, Clin Pharmacol & Safety Sci, Clin Pharmacol & Quantitat Pharmacol, Gothenburg, Sweden. (creator_code:org_t)
Elsevier, 2022
2022
Engelska.
Ingår i: Journal of Pharmaceutical Sciences. - : Elsevier. - 0022-3549 .- 1520-6017. ; 111:3, s. 852-858
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Following inhaled dosing, broncho-alveolar lavage (BAL) is often used for sampling epithelial lining fluid (ELF) to determine drug concentration in the lungs. This study aimed to explore the technique's suitability. Urea is typically used to estimate the dilution factor between the BAL fluid and physiological ELF, since it readily permeates through all fluids in the body. As representatives of permeable small molecule drugs with high, medium and low tissue distribution properties, propranolol, diazepam, indomethacin and AZD4721 were infused intravenously to steady state to ensure equal unbound drug concentrations throughout the body. The results showed that propranolol had higher unbound concentrations in the ELF compared to the plasma whilst this was not the case for the other compounds. Experiments with different BAL volumes and repeated lavaging indicated that the amount of drug extracted is very sensitive to experimental procedure. In addition, the results show that the unbound concentrations in ELF compared to plasma differs dependent on molecule class and tissue distribution properties. Overall data suggests that lavaging can remove drug from lung tissue in addition to ELF and highlights significant uncertainty in the robustness of the procedure for determining ELF drug concentrations. (c) 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Nyckelord

Pulmonary drug delivery
Pharmacokinetics
Distribution
Protein binding
Tissue partition

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy